
GITNUXSOFTWARE ADVICE
Data Science AnalyticsTop 10 Best Real World Data Services of 2026
Ranked roundup of top real world data services for pharma analytics teams, with technical notes and tradeoffs from TriNetX, Clarify Health, OM1.
How we ranked these tools
Core product claims cross-referenced against official documentation, changelogs, and independent technical reviews.
Analyzed video reviews and hundreds of written evaluations to capture real-world user experiences with each tool.
AI persona simulations modeled how different user types would experience each tool across common use cases and workflows.
Final rankings reviewed and approved by our editorial team with authority to override AI-generated scores based on domain expertise.
Score: Features 40% · Ease 30% · Value 30%
Gitnux may earn a commission through links on this page — this does not influence rankings. Editorial policy
TriNetX is the best fit for pharma teams that need rapid, governed retrospective cohort iterations using a global EHR network, whereas Clarify Health works better if your analytics team wants provider-managed cohort construction for repeatable RWE studies.
Editor’s top 3 picks
Three quick recommendations before you dive into the full comparison below — each one leads on a different dimension.
TriNetX
Interactive cohort execution with study workspaces that produce temporality-aware outcome summaries.
Built for fits when pharma teams need rapid retrospective cohort iterations with governed access..
Clarify Health
Editor pickCohort-focused delivery that turns study specifications into analytics-ready datasets with controlled inclusion and variable definitions.
Built for fits when pharma analytics teams want provider-managed cohort construction for repeatable RWE studies..
OM1
Editor pickAPI-driven cohort provisioning with governance-ready audit trails for repeat study operations.
Built for fits when pharma analytics teams need governed, repeatable cohort builds with automation hooks..
Comparison Table
TriNetX
enterprise_vendorGlobal network of electronic health record data for real-world evidence and clinical trial optimization.
Interactive cohort execution with study workspaces that produce temporality-aware outcome summaries.
TriNetX is designed around interactive cohort discovery where investigators define populations with diagnoses, procedures, medications, and longitudinal events, then review follow-up windows and outcome hits. The platform’s real differentiator is operationalizing “study-ready” cohort counts and temporality for many common pharmacoepidemiology workflows without requiring teams to build extract pipelines. Automation is handled through saved queries, reusable cohort definitions, and study workspaces that multiple stakeholders can operate within controlled permissions.
A key tradeoff is that cohort logic expressiveness depends on what partner data capture supports consistently across the network, so certain nuanced clinical concepts may yield fewer matches or require alternate definitions. TriNetX fits best when teams need fast retrospective cohort iterations for comparative studies and for feedstock datasets for downstream statistical modeling, especially when integration bandwidth is limited.
- +Cohort queries deliver counts and outcome timelines without custom data engineering
- +Saved cohorts and study workspaces support repeatable analysis workflows
- +Controlled access model limits who can run queries and view results
- +De-identified export supports downstream statistical tooling
- –Concept granularity can vary by source, reducing matches for narrow phenotypes
- –Advanced analytic outputs still require external modeling after exports
Epidemiology and outcomes teams
Time-to-event cohort comparisons
Faster protocol-ready results
Real-world evidence statisticians
Feedstock creation for modeling
Shorter analysis build cycles
Show 1 more scenario
Medical affairs analytics
Safety and utilization snapshots
Consistent cross-cohort reporting
Run medication and diagnosis-based cohorts to quantify outcomes over consistent time windows.
Best for: Fits when pharma teams need rapid retrospective cohort iterations with governed access.
Clarify Health
enterprise_vendorReal-world data and analytics platform delivering patient journey insights for life sciences and providers.
Cohort-focused delivery that turns study specifications into analytics-ready datasets with controlled inclusion and variable definitions.
Clarify Health’s delivery model targets operational use cases where datasets must be assembled, normalized, and prepared for retrospective study analysis. The engagement pattern emphasizes provider-managed work on data acquisition and harmonization so analysts spend less time wiring raw extracts into study workflows. The practical fit is strongest when the study specification is clear and repeated across similar protocols. The service also suits teams that need consistent cohort construction across multiple research questions.
A key tradeoff is dependency on Clarify Health’s provisioning cadence for each study specification rather than self-serve configuration by internal teams. Teams often see faster turnaround when cohort logic and analytic requirements are defined early, including variables needed for confounding control and subgrouping. A common usage situation is retrospective cohort analysis where eligibility, index dates, and outcomes must be operationalized consistently across sites and time windows.
- +Provider-managed dataset assembly reduces internal extraction and harmonization work
- +Study-ready cohort logic supports repeatable retrospective analytics
- +Traceable curation helps teams reason about inclusion and analytic variable definitions
- +Delivery aligns with pharma study specifications instead of generic data drops
- –Study-specific provisioning cadence can limit rapid iteration on changing cohort rules
- –APIs and automation surface may not match teams that require self-serve programmatic access
- –Governance artifacts may arrive with deliverables instead of supporting continuous in-platform controls
- –Works best with analysts who can specify outcomes, windows, and eligibility up front
pharma epidemiology teams
Retrospective cohort for treatment effectiveness
Faster cohort readiness
biostatistics teams
Multi-subgroup confounding adjustment
More consistent modeling
Show 2 more scenarios
medical affairs analytics
Program evaluation across indications
Comparable cross-program outputs
Assembles comparable cohorts so observational endpoints can be measured consistently across programs.
real-world evidence leads
Protocol standardization across studies
Lower study-to-study drift
Replicates cohort construction rules to reduce variation between analysts and study cycles.
Best for: Fits when pharma analytics teams want provider-managed cohort construction for repeatable RWE studies.
OM1
enterprise_vendorReal-world data, outcomes, and AI company focused on chronic disease and specialty condition registries.
API-driven cohort provisioning with governance-ready audit trails for repeat study operations.
OM1 is geared toward teams that need consistent cohort definitions across studies, with workflows that emphasize repeatable data preparation steps. The service supports controlled access through RBAC and includes data provenance tracking so analysts can audit how a cohort was constructed. Automation via an API helps operationalize cohort creation and refresh cycles without relying on manual exports.
A key tradeoff is that deeper custom transformations may require more integration effort than approaches that primarily deliver turnkey datasets. OM1 fits situations where multiple internal stakeholders need aligned cohort outputs for retrospective cohort analysis and study planning, with tight governance around who can view and derive datasets.
- +Cohort workflows emphasize repeatability across recurring study questions
- +API-driven cohort provisioning supports automated refresh pipelines
- +RBAC and audit trails reduce governance friction for shared teams
- +Provenance tracking helps validate data transformations for cohorts
- –Custom study logic beyond standard preparations needs extra engineering time
- –Some advanced integration patterns depend on OM1 workflow conventions
Epidemiology and outcomes analysts
Rapid cohort builds for evidence generation
Faster study start cycles
Clinical data science teams
Automated cohort refresh for protocol updates
Lower cohort maintenance effort
Show 1 more scenario
Pharma BI and analytics governance
Shared access with controlled derivations
More auditable analytics
RBAC and provenance tracking support controlled access to derived datasets.
Best for: Fits when pharma analytics teams need governed, repeatable cohort builds with automation hooks.
Datavant
enterprise_vendorHealth data connectivity company enabling real-world data linkage across fragmented datasets.
Configurable privacy-first matching workflows that support governed patient identity resolution across partner datasets.
Datavant targets pharma analytics teams that need controlled patient data exchange across EHR and claims sources with an emphasis on linkage governance. Its core capability is identity resolution built for deterministic and probabilistic record matching, with configurable privacy controls that support de-identified and limited-access workflows.
Datavant also provides APIs and automation hooks for provisioning, partner onboarding, and data exchange orchestration across multiple data owners. The resulting delivery model is oriented toward repeatable pipelines for longitudinal cohort assembly and retargeted analytics rather than one-off extracts.
- +Identity resolution supports governed cross-source linkage for downstream cohort analytics
- +API surface supports automated provisioning and data exchange orchestration
- +Privacy controls are designed around de-identified and limited-access exchange patterns
- +Operational patterns fit recurring partner onboarding and re-linking workflows
- –Integration requires upfront mapping of partner data and matching configuration
- –Operational ownership shifts to the integration team for end-to-end pipeline validation
Best for: Fits when pharma teams need repeatable, governed patient linkage and automated exchange across multiple data holders.
Evidation
enterprise_vendorDigital real-world data company measuring health outcomes through connected devices and patient surveys.
Cohort provisioning workflows that turn patient and digital signals into reusable, controlled study datasets.
Evidation runs data capture and research-grade linkage workflows to create longitudinal, de-identified datasets from patient and health signals. Core capabilities include sourcing from digital health inputs and harmonizing outcomes for retrospective and prospective observational studies.
An integration-heavy setup connects data ingestion, identity resolution and pseudonymization, and downstream analytics use cases for pharma teams. Delivery focuses on controlled access for study cohorts and repeatable dataset refresh patterns.
- +End-to-end workflows for translating digital health signals into study-ready cohorts
- +Strong governance around de-identification and study cohort access controls
- +Repeatable dataset refresh supports longitudinal analysis without rebuilding pipelines
- +Practical automation hooks for ingestion and cohort provisioning into external analytics
- –Integration depth requires careful upfront mapping for source-to-cohort definitions
- –Limited transparency into standardized interoperability layers compared with EHR-first vendors
Best for: Fits when pharma analytics teams need longitudinal, de-identified cohorts built from digital health inputs.
Verana Health
enterprise_vendorReal-world data company curating clinical registry data from specialty medical societies.
Study execution orchestration that ties data preparation, cohort logic, and quality checks to sponsor-ready observational outputs.
Verana Health supports real-world data programs focused on clinical research workflows, with managed services that translate partner data into analysis-ready outputs. It is most distinct in how study pipelines connect governance, data access coordination, and observational analysis needs across multiple data sources.
Core capabilities include longitudinal cohort assembly, protocol-aligned data preparation, and quality checks that support RWE deliverables. The delivery model is geared toward pharma teams that need repeatable analytics runs rather than one-off extract requests.
- +Operational support for end-to-end cohort building and study execution
- +Repeatable pipeline patterns that reduce manual extract and recode cycles
- +Quality-focused preparation designed to support observational analysis validity
- +Clear focus on longitudinal evidence generation from messy clinical records
- –Automation depth is more service-led than API-first for custom integration
- –Surface area for self-serve data exploration appears narrower than analytics-only tools
- –Higher dependency on partner data readiness and ingestion coordination
- –Turnaround can be constrained by study scoping and governance reviews
Best for: Fits when pharma teams need managed observational pipelines from partner data to RWE deliverables.
HealthVerity
enterprise_vendorReal-world data marketplace connecting pharma to de-identified claims, EHR, and consumer health datasets.
Privacy-forward identity resolution and linkage service designed for multi-source longitudinal records.
HealthVerity centers its real world data access on a privacy-forward identity resolution layer that connects records across sources without exposing direct identifiers. The service supports longitudinal analytics by linking EHR and claims records into person-level histories for retrospective cohort work and measurement.
Integration is built around API-driven ingestion and query patterns, with configuration options that control how data is matched, governed, and delivered to analytics users. For pharma teams, HealthVerity is often evaluated for how consistently it can provide data provenance and linkage coverage across multi-source studies.
- +Identity resolution that enables cross-source longitudinal person-level linkage
- +API-driven delivery supports reproducible RWE pipelines and cohort refreshes
- +Governance-oriented handling focuses on privacy constraints for downstream analysis
- +Provenance support helps trace where linked attributes originate
- –Cohort results depend on linkage coverage that varies by data source
- –Setup requires disciplined data governance and study configuration choices
Best for: Fits when pharma analytics teams need governed identity resolution to build cross-source longitudinal cohorts.
Truveta
enterprise_vendorHealth system-owned real-world data venture providing de-identified EHR data for medical research.
Governance-led research data access workflow paired with an automation-friendly programmatic interface for repeat cohort extracts.
Truveta centralizes longitudinal patient data by ingesting multiple health source types and then publishing analysis-ready datasets and query interfaces for research and analytics. Its differentiation comes from offering a governance-oriented data access workflow around de-identified, research-use records plus a programmatic interface for repeated cohort extraction.
Truveta supports pharma use cases that need fast iteration on real-world cohorts, including settings where data provenance and documentation matter for downstream analysis. Core value is measured by how reliably teams can automate data provisioning and run repeatable extract logic across time and study waves.
- +Automates repeated cohort extraction through a documented programmatic access path
- +Provides de-identified research records with a clear governance workflow
- +Supports longitudinal analyses using linked patient histories across source types
- +Enables iterative study development without rebuilding extract logic each time
- –Requires disciplined governance for consistent approvals and controlled data access
- –Cohort logic often needs careful mapping across heterogeneous source coding patterns
Best for: Fits when pharma analytics teams need repeatable, governed cohort provisioning for longitudinal RWE studies.
IQVIA
enterprise_vendorGlobal provider of real-world data, real-world evidence, and clinical research services for pharma and biotech.
Managed cohort construction with study governance artifacts tied to data lineage and data provenance reporting.
IQVIA delivers real-world data services that combine curated healthcare data assets with analytics workflows for pharma evidence generation. Its core work centers on sourcing, linking, and transforming large-scale datasets into study-ready analytic environments used for retrospective and prospective observational designs.
IQVIA also provides operational support for cohort construction, variable engineering, and study governance through documented data handling processes. For pharma analytics teams, the distinctive factor is breadth of data coverage paired with end-to-end delivery that reduces the need to assemble multiple vendors for each RWE study.
- +End-to-end study delivery from data access through cohort build and analysis-ready outputs
- +Strong data curation focus for longitudinal patient records derived from multiple source types
- +Proven linking and normalization workflows for observational cohort analyses
- +Governance artifacts for data provenance and study audit trails
- –Automation depth varies by workflow and often requires vendor-assisted configuration
- –API and self-serve extensibility are less central than managed delivery
- –Complex studies need tighter upfront requirements to avoid rework
- –Some specialty domains rely on specific source availability and coverage
Best for: Fits when pharma teams need managed RWE execution and governance-heavy study workflows.
Picnic Health
enterprise_vendorPatient-driven real-world data collection service that recruits patients and compiles their medical records.
Provenance-focused transformation documentation that ties extracted fields to downstream analytic-ready datasets.
Picnic Health is a real world data service for pharma teams that need end-to-end data sourcing, transformation, and analytics delivery from healthcare sources. The service focuses on longitudinal patient records built for observational studies and retrospective analyses, with work products aligned to study design needs like cohort definition and outcome capture.
Picnic Health also provides governance-oriented handling of sensitive health data through de-identification workflows and provenance tracking for downstream auditability. Engagements typically combine data access coordination, cleaning and quality checks, and analytic readiness support for RWE teams.
- +End-to-end study data preparation paired with analytic delivery support
- +Longitudinal record construction supports retrospective cohort work
- +De-identification workflows designed for controlled data use
- +Data provenance artifacts reduce rework during data quality disputes
- –API and self-serve configuration surface is limited versus software-first vendors
- –Cohort reproducibility depends on documented extraction and transformation settings
- –Data ingestion timelines can be constrained by source access coordination
- –Advanced interoperability work may require deeper integration planning
Best for: Fits when pharma RWE teams need clinician-grade cohort datasets with managed data sourcing and transformation.
Conclusion
After evaluating 10 data science analytics, TriNetX stands out as our overall top pick — it scored highest across our combined criteria of features, ease of use, and value, which is why it sits at #1 in the rankings above.
Use the comparison table and detailed reviews above to validate the fit against your own requirements before committing to a tool.
How to Choose the Right real world data
Pharma analytics teams evaluating real world data services need delivery paths that start from source governance and end with cohort outputs that support retrospective and observational study work. This guide covers TriNetX, Clarify Health, OM1, Datavant, Evidation, Verana Health, HealthVerity, Truveta, IQVIA, and Picnic Health, with emphasis on how each vendor operationalizes cohort execution, identity resolution, and dataset delivery.
Service differences show up in integration depth, automation and API surface, and governance controls around who can build, refresh, and reuse study cohorts. TriNetX is positioned for interactive cohort execution with study workspaces, while OM1 is positioned for API-driven cohort provisioning with governance-ready audit trails.
Real world data services for pharma analytics deliver governed cohort access to longitudinal patient records
Real world data is longitudinal patient information sourced from healthcare and digital domains that gets organized into analysis-ready cohorts for real world evidence work. In practice, TriNetX supports rapid retrospective cohort iterations through study workspaces that produce temporality-aware outcome summaries.
Some vendors focus on provider-managed cohort construction, where Clarify Health turns study specifications into analytics-ready datasets using controlled inclusion and variable definitions. Other vendors focus on identity resolution and governed cross-source linkage, where Datavant and HealthVerity deliver privacy-forward matching workflows that enable longitudinal person-level records before cohort analytics.
Real world data capabilities that drive cohort speed, repeatability, and governance
Pharma analytics teams usually need a repeatable path from source-level governance to cohort-level outputs, because retrospective and observational study work repeats cohort logic across iterations and cohorts. Vendors differ most in how that path is operationalized through cohort workspaces, cohort construction workflows, and identity resolution services.
Cohort execution inside governed study workspaces
TriNetX supports interactive cohort execution with study workspaces that produce temporality-aware outcome summaries for rapid retrospective iterations. This approach reduces custom data engineering when cohort queries need counts and outcome timelines.
Provider-managed cohort assembly from study specifications
Clarify Health turns study specifications into analytics-ready datasets using controlled inclusion and variable definitions. OM1 supports API-driven cohort provisioning with governance-ready audit trails to support recurring study questions.
Governed patient identity resolution for cross-source longitudinal cohorts
Datavant provides configurable privacy-first matching workflows for governed patient identity resolution across partner datasets. HealthVerity delivers privacy-forward identity resolution and linkage service for multi-source longitudinal person-level records.
Automation depth for repeatable cohort provisioning and extraction
Truveta pairs governed research data access workflow with an automation-friendly programmatic interface for repeat cohort extracts. OM1 also emphasizes automated refresh pipelines through API-driven cohort provisioning and governance-ready audit trails.
End-to-end managed delivery with governance artifacts and lineage reporting
IQVIA delivers managed cohort construction with study governance artifacts tied to data lineage and data provenance reporting. Picnic Health focuses on provenance-focused transformation documentation that ties extracted fields to analytic-ready longitudinal datasets.
Choose by how cohort logic is executed, automated, and governed end-to-end
The right vendor depends on whether cohort logic runs as an interactive workspace, as provider-managed dataset assembly, or as API-driven provisioning that feeds automated pipelines. Each model changes the admin workload, the degree of programmatic control, and the speed of iteration when inclusion rules or phenotype definitions change.
Select an execution model that matches cohort iteration needs
Choose TriNetX when iterative cohort execution requires temporality-aware outcome summaries directly from study workspaces. Choose Clarify Health when provider-managed dataset assembly should turn study specifications into analytics-ready datasets with controlled inclusion and variable definitions.
If cohort refresh must be automated, prioritize API-driven provisioning
Choose OM1 when cohort provisioning needs API-driven automation hooks and governance-ready audit trails for repeat study operations. Choose Truveta when repeat cohort extraction must run through a documented programmatic access path paired with a governed access workflow.
If cross-source linkage coverage is the critical dependency, evaluate identity resolution providers
Choose Datavant when governed patient identity resolution must support privacy-first matching workflows across multiple data holders for downstream cohort analytics. Choose HealthVerity when multi-source longitudinal person-level linkage must be governed by a privacy-forward identity resolution and linkage service.
Match managed delivery scope to required study governance artifacts
Choose IQVIA when managed end-to-end delivery needs governance artifacts tied to data lineage and data provenance reporting for sponsor-ready study workflows. Choose Picnic Health when provenance-focused transformation documentation must tie extracted fields to analytic-ready longitudinal datasets that support retrospective cohort work.
Decide whether the workflow needs orchestration or software-first self-serve interfaces
Choose Verana Health when managed observational pipeline patterns must tie data preparation, cohort logic, and quality checks to sponsor-ready observational outputs. Choose Evidation when longitudinal, de-identified cohort provisioning must translate digital health signals into reusable controlled study datasets with governance around de-identification.
Which pharma teams should use each real world data service
These services fit pharma analytics teams based on how much work should happen inside the vendor workflow versus in-house pipelines. The strongest match also depends on whether the team is building cohorts from EHR-like longitudinal records, digital health inputs, or privacy-governed identity resolution layers.
Pharma biostatistics teams running repeated retrospective cohort iterations
TriNetX supports interactive cohort execution with study workspaces that produce temporality-aware outcome summaries, which reduces manual rework during phenotype refinement.
Pharma RWE teams requiring provider-managed cohort construction with defined inclusion rules
Clarify Health focuses on turning study specifications into analytics-ready datasets with controlled inclusion and variable definitions to support repeatable retrospective analytics.
Pharma analytics teams building longitudinal cohorts across multiple partner datasets
Datavant and HealthVerity provide privacy-forward identity resolution and linkage service that determines cross-source longitudinal person-level coverage before cohort analysis.
Pharma teams that need API-driven automation for cohort refresh pipelines
OM1 emphasizes API-driven cohort provisioning with governance-ready audit trails, while Truveta provides a documented programmatic access path for repeated cohort extraction.
Pharma governance-heavy study teams requiring lineage and provenance artifacts tied to delivery
IQVIA delivers managed cohort construction with study governance artifacts tied to data lineage and data provenance reporting, while Picnic Health documents transformation provenance tied to analytic-ready datasets.
Common pitfalls when buying real world data services for cohort analytics
Many buying teams misalign the evaluation criteria with the actual bottleneck in study work. Cohort iteration speed can fail when study logic is not executed in the right workflow layer, or when identity resolution coverage is assumed without validation.
Choosing an identity resolution vendor without validating linkage coverage for the intended sources
HealthVerity explicitly notes that cohort results depend on linkage coverage that varies by data source, so linkage coverage must be treated as a key dependency rather than a hidden internal step.
Assuming self-serve APIs match managed workflows without checking automation surface and configuration ownership
Clarify Health limits rapid iteration when study-specific provisioning cadence slows changing cohort rules, while IQVIA varies automation depth by workflow and often requires vendor-assisted configuration.
Relying on cohort exports for advanced analysis without accounting for what remains outside the vendor workflow
TriNetX cohort queries deliver counts and outcome timelines without custom data engineering, but advanced analytic outputs still require external modeling after exports.
Underestimating setup effort for partner mapping and matching configuration in governed linkage pipelines
Datavant calls out that integration requires upfront mapping of partner data and matching configuration, so pipeline validation ownership shifts to the integration team for end-to-end validation.
How We Selected and Ranked These Providers
We evaluated TriNetX, Clarify Health, OM1, Datavant, Evidation, Verana Health, HealthVerity, Truveta, IQVIA, and Picnic Health using feature coverage weighted at 40% plus ease and value each weighted at 30%. We kept category-specific scoring grounded in operational mechanisms such as cohort workspaces that produce temporality-aware outcomes, provider-managed dataset assembly from study specifications, API-driven cohort provisioning with governance-ready audit trails, and privacy-first identity resolution with governed matching workflows.
TriNetX ranked highest because interactive cohort execution with study workspaces produced temporality-aware outcome summaries and supported repeatable analysis workflows through saved cohorts and study workspaces without requiring custom data engineering for counts and outcome timelines. We treated tradeoffs as scoring inputs, including cases where concept granularity varies by source for narrow phenotypes in TriNetX and cases where study-specific provisioning cadence can limit rapid iteration in Clarify Health.
Frequently Asked Questions About real world data
How do TriNetX and OM1 differ in cohort definition workflow and output granularity?
Which service providers provide API-driven cohort provisioning and what does that enable for automation?
When do pharma teams use identity resolution services like Datavant and HealthVerity instead of relying on source-native identifiers?
What breaks when an RWD project needs provenance and audit artifacts tied to analytic-ready transformations?
How do Clarify Health and Verana Health handle fit-for-purpose dataset preparation from fragmented sources?
What does data migration involve when switching from one RWD workflow to another provider?
Where does HealthVerity fall short compared with Datavant for privacy controls and linkage configuration needs?
How do Evidation and Picnic Health differ when the source mix includes digital health signals and clinical outcomes?
Which providers are designed for study execution orchestration rather than one-off data extract requests?
Tools reviewed
Primary sources checked during evaluation.
Referenced in the comparison table and product reviews above.
- Data Science AnalyticsTop 10 Best Real Time Data Services of 2026
- Technology Digital MediaTop 10 Best Data Web Services of 2026
- Data Science AnalyticsTop 10 Best Real Estate Data Services of 2026
- Business FinanceTop 10 Best Real World Software of 2026
- Data Science AnalyticsTop 10 Best Data Services Software of 2026
Keep exploring
Comparing two specific tools?
Software Alternatives
See head-to-head software comparisons with feature breakdowns, pricing, and our recommendation for each use case.
Explore software alternatives→In this category
Data Science Analytics alternatives
See side-by-side comparisons of data science analytics tools and pick the right one for your stack.
Compare data science analytics tools→